Phys Vivas · dermatological
Pyoderma Gangrenosum AND Neutrophilic Dermatoses — Viva Defence
DCE viva defence for Pyoderma Gangrenosum AND Neutrophilic Dermatoses.
On this page
Study tools
Target exams
Pyoderma Gangrenosum AND Neutrophilic Dermatoses Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Pyoderma Gangrenosum AND Neutrophilic Dermatoses. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References8ShowHide
- [1]Balan K, Elston DM IL-1-targeted therapy in dermatologic conditions J Am Acad Dermatol, 2026.PMID 42264383
- [2]Kerniss H, Olbrich H, Curman P, Ständer S, et al. Pyoderma gangrenosum is associated with excess incident major atherothrombotic events Atherosclerosis, 2026.PMID 42263577
- [3]Rahman S, Akuffo-Addo E, Geng R, Bestavros S, et al. Genital Pyoderma Gangrenosum: A Systematic Review of Reported Cases and Treatment Outcomes J Cutan Med Surg, 2026.PMID 42109214
- [4]Haddadin OM, Jacobson ME, Becker SL, Chen D, et al. Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus Br J Dermatol, 2026.PMID 41784109
- [5]Yamamoto T, Yamasaki K, Yamanaka K, Komine M, et al. Clinical guidance of pyoderma gangrenosum 2022 J Dermatol, 2023.PMID 37311717
- [6]Maverakis E, Ma C, Shinkai K, Fiorentino D, et al. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts JAMA Dermatol, 2018.PMID 29450466
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922